We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current AGY market cap is 142.99M. The company's latest EPS is GBP -0.0090 and P/E is -3.33.
Year End 30 June 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
GBP (£) | GBP (£) | GBP (£) | GBP (£) | GBP (£) | |
Total Revenue | 73.72M | 78.2M | 84.33M | 72.77M | 59.59M |
Operating Income | 4.98M | 10.06M | 2.03M | -12.22M | -38.77M |
Net Income | 3.47M | 7.06M | 2.89M | -13.78M | -43.07M |
Year End 30 June 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
GBP (£) | GBP (£) | GBP (£) | GBP (£) | GBP (£) | |
Total Assets | 68.5M | 86.23M | 88.09M | 73.58M | 66.77M |
Total Liabilities | 30.94M | 42.44M | 39.55M | 35.18M | 64.7M |
Total Equity | 37.56M | 43.78M | 48.54M | 38.4M | 2.07M |
Year End 30 June 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
GBP (£) | GBP (£) | GBP (£) | GBP (£) | GBP (£) | |
Operating | 5.6M | 12.01M | 8.4M | -13.82M | -28.88M |
Investing | -3.35M | -2.51M | -2.64M | -3.18M | -4.59M |
Financing | 9.55M | -110k | -2.03M | -2.81M | 27.8M |
Market Cap | 142.99M |
Price to Earnings Ratio | -3.33 |
Price to Sales Ratio | 2.4 |
Price to Cash Ratio | 9.68 |
Price to Book Ratio | 69.21 |
Dividend Yield | - |
Shares Outstanding | 4.77B |
Average Volume (1 week) | 635.73k |
Average Volume (1 Month) | 1.05M |
52 Week Change | -7.69% |
52 Week High | 3.80 |
52 Week Low | 0.85 |
Spread (Intraday) | 0.4 (12.5%) |
Company Name | Allergy Therapeutics Plc |
Address |
dominion way west sussex BN14 8SA |
Website | https://www.allergytherapeutics.com |
Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions